The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III randomized, open-label study to establish the superiority of triple oral metronomic therapy (OMCT) used in addition to chemotherapy regimen (paclitaxel + carboplatin) over chemotherapy alone for the treatment of advanced unresectable head and neck cancer squamous cell cancer (HNSCC).
 
Akhil Kapoor
Research Funding - AstraZeneca (Inst); Bayer (Inst); Biocon (Inst); Lilly (Inst); Novartis (Inst)
 
Anuj Gupta
No Relationships to Disclose
 
Bipinesh Sansar
No Relationships to Disclose
 
Bal Krishna Mishra
No Relationships to Disclose
 
Pooja Gupta
No Relationships to Disclose
 
Arpita Singh
No Relationships to Disclose
 
Ankita Rungta Kapoor
No Relationships to Disclose
 
Sambit Swarup Nanda
No Relationships to Disclose
 
Ashutosh Mukherji
No Relationships to Disclose
 
Rukmeena Kumari
No Relationships to Disclose
 
Ankita Pal
No Relationships to Disclose
 
Satyendra Narayan Singh
No Relationships to Disclose
 
Aseem Mishra
No Relationships to Disclose
 
Ipsita Dhal
No Relationships to Disclose
 
Kunal Ranjan Vinayak
No Relationships to Disclose
 
SOMNATH DEY
No Relationships to Disclose
 
Vanita Noronha
Research Funding - AstraZeneca (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); Nanobiotix (Inst); Novartis (Inst); Roche India (Inst)
Travel, Accommodations, Expenses - American Society of Clinical Oncology
 
Vijay Maruti Patil
Research Funding - AstraZeneca (Inst); Eisai Germany (Inst); Intas (Inst); Johnson & Johnson/Janssen (Inst); NATCO Pharma (Inst); Novartis (Inst)
 
Shripad Dinanath Banavali
No Relationships to Disclose
 
Kumar Prabhash
Research Funding - Alkem Laboratories (Inst); BDR Pharmaceutics (Inst); Biocon (Inst); Dr. Reddy's Laboratories (Inst); Fresenius Kabi (Inst); NATCO Pharma (Inst); Roche (Inst)